\
&
Contact us
\
&
Contact us
Starts in 2 days from now
Locationonline
ProgrammesThe info day will focus on the 2025 calls of the Horizon Europe Research Infrastructures work programme 2025, for its main destinations.
The info day will also offer horizontal information on the submission, evaluation and management of the 2025 Research Infrastructures calls. In addition, the Q&A sessions will give participants the opportunity to ask any remaining questions.
The programme and more details on how to participate will be made available shortly. For all up to date information on this info day please visit the announcement on the research and innovation community platform of the European Commission.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
